These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37898869)

  • 1. Evaluating the Effectiveness of a Modified Colorectal Cancer Screening Program in Almaty, Kazakhstan.
    Zholmurzayeva R; Ospanova D; Dzhumabekov A; Noso Y; Talkimbayeva N; Aytmanbetova A; Ussebayeva N; Zhorayev T; Fakhradiyev I
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3605-3611. PubMed ID: 37898869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, Attitudes, and Barriers (KABs) of Regarding Colorectal Cancer Screening among the Population of the Republic of Kazakhstan.
    Toleutayeva D; Shalgumbayeva GM; Toleutayev TA; Kudaibergenova NK
    Asian Pac J Cancer Prev; 2022 Jun; 23(6):2057-2063. PubMed ID: 35763648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.
    Segnan N; Armaroli P; Bonelli L; Risio M; Sciallero S; Zappa M; Andreoni B; Arrigoni A; Bisanti L; Casella C; Crosta C; Falcini F; Ferrero F; Giacomin A; Giuliani O; Santarelli A; Visioli CB; Zanetti R; Atkin WS; Senore C;
    J Natl Cancer Inst; 2011 Sep; 103(17):1310-22. PubMed ID: 21852264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Breast, Cervical and Prostate Cancers in Kazakhstan: Key Factors and Psychological Aspects.
    Shamsutdinova A; Turdaliyeva B; Tanabayeva S; Omarova A; Saliev T; Tanabayev B; Fakhradiyev I
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2515-2522. PubMed ID: 37505786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of comorbid conditions on adherence to colorectal cancer screening.
    Lukin DJ; Jandorf LH; Dhulkifl RJ; Thélémaque LD; Christie JA; Itzkowitz SH; Duhamel KN
    J Cancer Educ; 2012 Jun; 27(2):269-76. PubMed ID: 22351374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients.
    Courtney RJ; Paul CL; Carey ML; Sanson-Fisher RW; Macrae FA; D'Este C; Hill D; Barker D; Simmons J
    BMC Cancer; 2013 Jan; 13():13. PubMed ID: 23305355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
    Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
    Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.
    Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2017 Nov; 123(22):4472-4480. PubMed ID: 28753230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored message interventions versus typical messages for increasing participation in colorectal cancer screening among a non-adherent population: A randomized controlled trial.
    Hirai K; Ishikawa Y; Fukuyoshi J; Yonekura A; Harada K; Shibuya D; Yamamoto S; Mizota Y; Hamashima C; Saito H
    BMC Public Health; 2016 May; 16():431. PubMed ID: 27220976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.
    Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP;
    Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.